ConclusionAt present, there is limited evidence to support the clinical use of cannabinoid therapies for the treatment of any sleep disorder given the dearth of published research and the moderate-to-high risk of bias identified within the majority of clinical and preclinical studies completed to-date. Nonetheless, there are promising signs in a number of therapeutic applications that warrant additional study and there is a clear need for intensification of high-quality research into the safety and
CBD and Insomnia, page-2
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $540 | 270K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 13918600 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 41116983 | 27 |
View Market Depth
| Last trade - 10.35am 05/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |